Atlas Trials

Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

Clinical trial NCT06933277 · RECRUITING

Trial details

NCT number
NCT06933277
Sponsor
Gruppo Italiano Malattie EMatologiche dell'Adulto
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2025-08-29
Primary completion
2028-08-01
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.